Pasithea Therapeutics Warrants
KTTAW
7 hedge funds and large institutions have $13.2K invested in Pasithea Therapeutics Warrants in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
0.37% more ownership
Funds ownership: 6.22% → 6.59% (+0.37%)
51% less capital invested
Capital invested by funds: $27K → $13.2K (-$13.8K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.77K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$265 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
| 2 |
CS
Clear Street
New York
|
-$2 |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $6.2K | – | – | – |
|
|
WAM
2
Warberg Asset Management
Winnetka,
Illinois
| $3.8K | -$2 | -100 | -0% |
|
|
KC
3
Kepos Capital
New York
| $2K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $1K | +$1.77K | +85,713 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $190 | +$265 | +12,826 | New |
|
|
CS
6
Clear Street
New York
| $1 | -$2 | -100 | -50% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1 | +$2 | +100 | New |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$2 | -100 | Closed |
|
KTTAW Hedge Fund Activity: Q3 2023 in Review
7 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pasithea Therapeutics Warrants (KTTAW) for Q3 2023, worth a combined $13.2K — down 51% from $27K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KTTAW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.77K. The largest seller was Bank of America, exiting entirely with an estimated $2 sold.
- 7 institutional investors held Pasithea Therapeutics Warrants (KTTAW) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $13.2K of Pasithea Therapeutics Warrants stock for Q3 2023, down 51% quarter-over-quarter.
- 3 funds opened new Pasithea Therapeutics Warrants positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Pasithea Therapeutics Warrants buyer in Q3 2023 was Virtu Financial, an estimated $1.77K added.
- The largest Pasithea Therapeutics Warrants seller in Q3 2023 was Bank of America, an estimated $2 sold.
Based on aggregated 13F filings for Q3 2023.